126 related articles for article (PubMed ID: 30842153)
1. Clinicopathological Significance of Autophagy-related Proteins and its Association With Genetic Alterations in Gliomas.
Tamrakar S; Yashiro M; Kawashima T; Uda T; Terakawa Y; Kuwae Y; Ohsawa M; Ohata K
Anticancer Res; 2019 Mar; 39(3):1233-1242. PubMed ID: 30842153
[TBL] [Abstract][Full Text] [Related]
2. High LC3/Beclin Expression Correlates with Poor Survival in Glioma: a Definitive Role for Autophagy as Evidenced by In Vitro Autophagic Flux.
Cj P; Hv E; Vijayakurup V; R Menon G; Nair S; Gopala S
Pathol Oncol Res; 2019 Jan; 25(1):137-148. PubMed ID: 29022195
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status.
Schmitz KJ; Ademi C; Bertram S; Schmid KW; Baba HA
World J Surg Oncol; 2016 Jul; 14(1):189. PubMed ID: 27444698
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Correlations of Autophagy-related Proteins LC3, Beclin 1 and p62 in Gastric Cancer.
Masuda GO; Yashiro M; Kitayama K; Miki Y; Kasashima H; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Masaichi O; Hirakawa K
Anticancer Res; 2016 Jan; 36(1):129-36. PubMed ID: 26722036
[TBL] [Abstract][Full Text] [Related]
5. Single-Prolonged-Stress-Induced Changes in Autophagy-Related Proteins Beclin-1, LC3, and p62 in the Medial Prefrontal Cortex of Rats with Post-traumatic Stress Disorder.
Zheng S; Han F; Shi Y; Wen L; Han D
J Mol Neurosci; 2017 May; 62(1):43-54. PubMed ID: 28341893
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy.
Park JM; Huang S; Wu TT; Foster NR; Sinicrope FA
Cancer Biol Ther; 2013 Feb; 14(2):100-7. PubMed ID: 23192274
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
[TBL] [Abstract][Full Text] [Related]
8. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
Houdova Megova M; Drábek J; Dwight Z; Trojanec R; Koudeláková V; Vrbková J; Kalita O; Mlcochova S; Rabcanova M; Hajdúch M
Klin Onkol; 2017; 30(5):361-371. PubMed ID: 29031038
[TBL] [Abstract][Full Text] [Related]
9. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds.
You H; Wu Y; Chang K; Shi X; Chen XD; Yan W; Li R
CNS Neurosci Ther; 2017 Oct; 23(10):790-797. PubMed ID: 28868656
[TBL] [Abstract][Full Text] [Related]
11. Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
Li MY; Wang YY; Cai JQ; Zhang CB; Wang KY; Cheng W; Liu YW; Zhang W; Jiang T
PLoS One; 2015; 10(6):e0130872. PubMed ID: 26115094
[TBL] [Abstract][Full Text] [Related]
12. TLR2 promotes development and progression of human glioma via enhancing autophagy.
Li C; Ma L; Liu Y; Li Z; Wang Q; Chen Z; Geng X; Han X; Sun J; Li Z
Gene; 2019 Jun; 700():52-59. PubMed ID: 30898699
[TBL] [Abstract][Full Text] [Related]
13. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
[TBL] [Abstract][Full Text] [Related]
14. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
[TBL] [Abstract][Full Text] [Related]
15. Investigating the Association between the Autophagy Markers LC3B,
Danish F; Qureshi MA; Mirza T; Amin W; Sufiyan S; Naeem S; Arshad F; Mughal N
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203743
[TBL] [Abstract][Full Text] [Related]
16. TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells.
Fu R; Ding Y; Luo J; Yu L; Li CL; Li DS; Guo SW
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28341638
[TBL] [Abstract][Full Text] [Related]
17. Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma.
Sakakura K; Takahashi H; Kaira K; Toyoda M; Oyama T; Chikamatsu K
Cancer Sci; 2015 Jan; 106(1):1-8. PubMed ID: 25338734
[TBL] [Abstract][Full Text] [Related]
18. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
Ogura R; Tsukamoto Y; Natsumeda M; Isogawa M; Aoki H; Kobayashi T; Yoshida S; Okamoto K; Takahashi H; Fujii Y; Kakita A
Neuropathology; 2015 Aug; 35(4):324-35. PubMed ID: 25950388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
